12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612279577/en/ENYO-Pharma-Announces-Completion-of-Series-C-Financing-With-Vesalius-Biocapital-and-Continued-Progress-of-Its-ALPESTRIA-1-Clinical-Phase-2-Study-in-Alport-Syndrome-Patients